Leptospira
Overview
Product sourcing insights & recommendations
The global market for Leptospira (Leptospirosis) products is undergoing a significant transformation, driven by climate change-related flooding events and a "prevention-first" model in both human and veterinary medicine. The Veterinary Leptospirosis Treatment Market is projected to grow from USD 0.9 billion in 2026 to USD 1.20 billion by 2031, at a CAGR of 5.94% GrandviewresearchMordorintelligence.
Market Trends & Drivers
* Climate Change Impact: Extreme rainfall and flooding in regions like India, Brazil, and Australia have spiked cases by up to tenfold, transitioning market demand from routine annual purchasing to "event-driven" contingency stockpiling Mordorintelligence.
* One-Health Initiatives: Governments are increasingly integrating veterinary vaccines into national disease-control budgets. For instance, Vietnam has mandated 80% coverage for livestock in high-risk zones Mordorintelligence.
* Shift in Veterinary Spend: In 2024, U.S. veterinary spending reached USD 41.26 billion, with pet owners increasingly bundling Leptospira boosters with comprehensive wellness panels Mordorintelligence.
Product Innovations
* Vaccines: Recent high-profile launches include Virbac's Canixin L (Jan 2026), a bivalent vaccine reducing urinary shedding, and Boehringer Ingelheim's EURICAN L4 (Dec 2025), which offers extended protection against four serogroups Mordorintelligence. MSD (Merck) also received a positive EMA opinion for its L6 multivalent vaccines in mid-2025 Mordorintelligence.
* Diagnostics: The market is rapidly pivoting from the traditional Microscopic Agglutination Test (MAT) toward Point-of-Care (POC) PCR and ELISA-based combo kits. Molecular tests now achieve 96.3% sensitivity, enabling diagnosis within 10–45 minutes compared to the previous six-day average MordorintelligenceMordorintelligence.
Sourcing Insights
Current B2B availability highlights a strong focus on rapid antibody detection kits for veterinary use, with prices ranging from $0.27 to $120 depending on technology (Lateral Flow vs. PCR).
Leptospira Rapid Test Kit Pcr Elisa Igg Igm Antibody Test
Products · Top picks & verified manufacturers
Canine Leptospira Rapid Test Kit Lepto Igg/igm ab Antibody Detection Urine Blood Sample Veterinary Clinics for Dog
CHONGQING SAFVET BIOTECH CO.,LTD🇨🇳CN5 yrs
Vamber Elisa test Kits Canine Infectious Hepatitis Parvovirus Distemper Virus Leptospira Toxoplasma IgG Antibody Combo Test
Hangzhou Itgen Technology Co., Ltd.🇨🇳CN6 yrs
Canine Leptospira IgG IgM Rapid Test, Dual-Antibody Staging for Rainy-Season & Endemic Areas, Serum, 10-Min, Distributor Price
Guangdong Weihui Biotechnology Co., Ltd.verified🇨🇳CN1 yr
Canine Leptospirosis Antibody Rapid Test Pet Rapid Detection Kit C.Lepto Ab test
Shanghai Best Vet Products Co., Ltd.🇨🇳CN1 yr
Human Leptospira IgG,Lep IgG ELISA Kit
Hangzhou Shenglong Import And Export Trade Co., Ltd.🇨🇳CN5 yrs
Human Lebtospira IgM antibody(Lep IgM) ELISA Kit
Hubei Province Youqian Biotechnology Co., Ltd.🇨🇳CN1 yr
Dog Disease Test Veterinary Test Kit Canine Leptospirosis Antibody Rapid Test Lifecosm RC-CF13 ISO13485 Certified
Lifecosm Biotech Limited🇨🇳CN2 yrs
High Accuracy Veterinary Canine Ehrlichia Babesia Anaplasma Leptospira Ab Antibody Combo Rapid Test Kit EHR BAB ANA LEP Zoonotic
Beijing Jiachuang Jiuhe Global Trade Co., Ltd.verified🇨🇳CN1 yr
Canine Leptospirosis Antibody Rapid Test Pet Rapid Detection Kit C.Lepto Ab test
JcMed (TIANJIN) IMPORT&EXPORT CO., LTD.verified🇨🇳CN9 yrs
Super September Pet Care Leptospira Antibody Test Lepto Veterinary Rapid Test Kit
Shanghai Petcare Biotech Co., Ltd.🇨🇳CN3 yrs
Lepto Ab Qualitative Detection Canine Leptospira Antibody Rapid Test Kit for Dog
Medsinglong Co Ltdverified🇨🇳CN8 yrs
Lepto Ab Qualitative Detection Canine Leptospira Antibody Rapid Test Kit for Dog Equipment
MEDSINGLONG CO LTDverified🇨🇳CN13 yrs
Lepto Ab Qualitative Detection Canine Leptospira Antibody Rapid Test Kit for Dog
MEDSINGLONG CO LTDverified🇨🇳CN6 yrs
Best-selling E. Canis/Anaplasma/Babesia/Leptospira/Lyme Canine and Feline Five-Component Antibody Veterinary Rapid Test Kit
Kit De Elisa Para Leptospira Lepto Ag Pet Products Fast Delivery No MOQ Pet Care Tests
Shanghai S&C Biotech.,Ltd🇨🇳CN7 yrs
Testsealabs High Quality Canine Leptospirosis Antibody Rapid Test Kit for Veterinary Lepto Test for Cat for Animal
Hangzhou Test Technology Co., Ltd.🇨🇳CN4 yrs
Leptospira Spp. Veterinary Real-Time PCR Detection Kit with Test Strips for Livestock Diagnosis VIUICK NCEP-D-0731 Safe Reliable
Guangzhou Viuick Biomedical Technology Co., Ltd.🇨🇳CN3 yrsRelated Searches
Explore more sourcing topics & related categories
Sources & References
57 sources cited · Verified industry data & reports
Respiratory Disease Vaccine Market Global Report 2026
www.marketresearch.com
Respiratory Disease Vaccine Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market. This report focuses respiratory disease vaccine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. 36.1. Respiratory Disease Vaccine Market Competitive Landscape And Market Share 2024 The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
Diagnostics Market Research Reports & Diagnostics Industry Analysis ...
www.marketresearch.com
The 2026 Global Clinical Laboratory Services Market Forecast (2027-2032 Outlook)-End-User Opportunities Report, published by Barnes Reports, contains timely and accurate market statistics and forecasts on the market. The product or service category is within the End-Users End-User base. The 2026 Global Transplant Diagnostics Market Forecast (2027-2032 Outlook)-Applications Opportunities Report, published by Barnes Reports, contains timely and accurate market statistics and forecasts on the market. The product or service category is within the Applications base. The 2026 Global Clinical Laboratory Services Market Forecast (2027-2032 Outlook)-Applications Opportunities Report, published by Barnes Reports, contains timely and accurate market statistics and forecasts on the market. The product or service category is within the Applications base. The 2026 North America Transplant Diagnostics Market Forecast (2027-2032 Outlook)-Applications Opportunities Report, published by Barnes Reports, contains timely and accurate market statistics and forecasts on the market. The product or service category is within the Applications base.
Ebola Market Research Reports & Ebola Industry Analysis | ...
www.marketresearch.com
Neglected Tropical Disease Treatment Market Summary The global neglected tropical disease treatment market size was estimated at USD 3.96 billion in 2024 and is projected to reach USD 6.04 billion by 2033, growing at a CAGR of 4.78% from 2025 to 2033. The demand for these treatments is driven by the ... ... Global Ebola Drugs and Vaccines Market to Reach US$145.5 Million by 2030 The global market for Ebola Drugs and Vaccines estimated at US$36.2 Million in the year 2024, is expected to reach US$145.5 Million by 2030, growing at a CAGR of 26.1% over the analysis period 2024-2030. The Neglected Tropical Diseases Drugs And Vaccines market is a thriving business that is poised to keep ... ... Neglected Tropical Disease Treatment Market Outlook Neglected Tropical Disease Treatment Market Size is forecast to register an optimistic growth rate of 5.1% from 2025 to 2032.. The Neglected Tropical Disease Treatment market is a thriving business that is poised to keep growing and presents potent ... ... Ebola Virus- Competitive Landscape, 2024 DelveInsight’s, “Ebola Virus- Competitive landscape, 2024,” report provides comprehensive insights about 18+ companies and 20+ drugs in Ebola Virus Competitive landscape. Ebola Virus Vaccine Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type This report describes the global market size of Ebola Virus Vaccine from 2019 to 2023 and its CAGR from 2019 to 2023, and also forecasts its market size to ... Global Ebola Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030 According to our (Global Info Research) latest study, the global Ebola Treatment market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % d ... ... Global Ebola Virus Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030 According to our (Global Info Research) latest study, the global Ebola Virus Vaccine market size was valued at USD 154.3 million in 2023 and is forecast to a readjusted size of USD 232.5 million ...
Global VLP-based Vaccine Market Research Report 2024(Status and ...
www.marketresearch.com
This report provides a deep insight into the global VLP-based Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
Vaccines Market Research Reports & Vaccines Industry Analysis | ...
www.marketresearch.com
Jul 01, 2024 | Published by: Plimsoll Publishing Ltd. ... million in 2023 and is anticipated to grow with a healthy growth rate of more than 5.18% over the forecast period 2024-2032. Vaccine logistics includes organizing and carrying out tasks associated with the distribution, delivery, ... ... USD 2850.2 million in 2023 and is anticipated to grow with a healthy growth rate of more than 5.20% over the forecast period 2024-2032. Vaccine logistics involves the planning and execution of activities related to ... ... valued approximately USD 798.06 million in 2023 and is anticipated to grow with a healthy growth rate of more than 6.20% over the forecast period 2024-2032. Vaccine logistics involves the planning, coordination, and execution of ...
Respiratory Disease Vaccine Market Size, Share & Trends Analysis ...
www.marketresearch.com
Based on type, the viral vaccine segment held the largest market share of 54.84% in 2024 owing to the increasing prevalence of viral respiratory conditions On the basis of infection, The COVID-19 segment held the largest market share of 40.03% in 2024 due to the growing need for the development of a vaccine to stop the spread of the COVID-19 virus 7.2. Respiratory Disease Vaccine Market: Distribution Channel Movement Analysis, 2024 & 2030 (USD Million) 8.1. Respiratory Disease Vaccine Market Share, By Region, 2024 & 2030, USD Million